BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19435429)

  • 1. Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women.
    Singh DK; Anastos K; Hoover DR; Burk RD; Shi Q; Ngendahayo L; Mutimura E; Cajigas A; Bigirimani V; Cai X; Rwamwejo J; Vuolo M; Cohen M; Castle PE
    J Infect Dis; 2009 Jun; 199(12):1851-61. PubMed ID: 19435429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).
    Kojic EM; Cu-Uvin S; Conley L; Bush T; Onyekwuluje J; Swan DC; Unger ER; Henry K; Hammer JH; Overton ET; Darragh TM; Palefsky JM; Vellozzi C; Patel P; Brooks JT
    Sex Transm Dis; 2011 Apr; 38(4):253-9. PubMed ID: 20966828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women.
    Anastos K; Hoover DR; Burk RD; Cajigas A; Shi Q; Singh DK; Cohen MH; Mutimura E; Sturgis C; Banzhaf WC; Castle PE
    PLoS One; 2010 Oct; 5(10):e13525. PubMed ID: 20976000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding.
    Theiler RN; Farr SL; Karon JM; Paramsothy P; Viscidi R; Duerr A; Cu-Uvin S; Sobel J; Shah K; Klein RS; Jamieson DJ
    Obstet Gynecol; 2010 Jun; 115(6):1150-1158. PubMed ID: 20502284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
    Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
    Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical human papillomavirus DNA detection in women living with HIV and HIV-uninfected women living in Limbe, Cameroon.
    Adedimeji A; Ajeh R; Dzudie A; Kendowo E; Fuhngwa N; Nsame D; Simo-Wambo AG; Orock E; Hebert TM; Pierz AJ; Murokora D; Anastos K; Castle PE
    J Clin Virol; 2020 Jul; 128():104445. PubMed ID: 32470891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the Human Papillomavirus Genotypes, According to the Human Immunodeficiency Virus Status in a Cohort of Women from Maputo, Mozambique.
    Maueia C; Murahwa A; Manjate A; Andersson S; Sacarlal J; Kenga D; Mussá T; Williamson AL
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era.
    Heard I; Poizot-Martin I; Potard V; Etienney I; Crenn-Hebert C; Moore C; Touraine P; Cubie H; Costagliola D;
    J Infect Dis; 2016 May; 213(9):1455-61. PubMed ID: 26690345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.
    Blossom DB; Beigi RH; Farrell JJ; Mackay W; Qadadri B; Brown DR; Rwambuya S; Walker CJ; Kambugu FS; Abdul-Karim FW; Whalen CC; Salata RA
    J Med Virol; 2007 Jun; 79(6):758-65. PubMed ID: 17457908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection with human papillomavirus and HIV among young women in Kampala, Uganda.
    Banura C; Franceschi S; Doorn LJ; Arslan A; Wabwire-Mangen F; Mbidde EK; Quint W; Weiderpass E
    J Infect Dis; 2008 Feb; 197(4):555-62. PubMed ID: 18237268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
    J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa.
    Marais DJ; Passmore JA; Denny L; Sampson C; Allan BR; Williamson AL
    J Med Virol; 2008 Jun; 80(6):953-9. PubMed ID: 18428143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-Year Trend in the Prevalence of High-Risk Human Papillomavirus Infection Among Rwandan Women Living With HIV.
    Murenzi G; Kanyabwisha F; Murangwa A; Kubwimana G; Mutesa L; Burk RD; Anastos K; Castle PE
    J Infect Dis; 2020 Jun; 222(1):74-81. PubMed ID: 32050023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.
    Moodley JR; Constant D; Hoffman M; Salimo A; Allan B; Rybicki E; Hitzeroth I; Williamson AL
    BMC Cancer; 2009 Aug; 9():275. PubMed ID: 19664216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015.
    Balanda M; Quiero A; Vergara N; Espinoza G; Martín HS; Rojas G; Ramírez E
    Med Microbiol Immunol; 2016 Dec; 205(6):585-594. PubMed ID: 27539577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
    Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
    PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women.
    Darwich L; Cañadas MP; Sirera G; Alameda F; Forcada P; Delas J; Fernández I; Llatjós M; Coll J; Clotet B; Videla S
    Int J Gynecol Cancer; 2011 Nov; 21(8):1486-90. PubMed ID: 21892092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.
    Langley CL; Benga-De E; Critchlow CW; Ndoye I; Mbengue-Ly MD; Kuypers J; Woto-Gaye G; Mboup S; Bergeron C; Holmes KK; Kiviat NB
    AIDS; 1996 Apr; 10(4):413-7. PubMed ID: 8728046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women.
    Obiri-Yeboah D; Akakpo PK; Mutocheluh M; Adjei-Danso E; Allornuvor G; Amoako-Sakyi D; Adu-Sarkodie Y; Mayaud P
    BMC Cancer; 2017 Oct; 17(1):688. PubMed ID: 29037188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence rate of cervical human papillomavirus infections and abnormal cytology in Rwanda.
    Mukanyangezi MF; Rugwizangoga B; Manzi O; Rulisa S; Hellstrand K; Tobin G; Martner A; Bienvenu E; Giglio D
    HIV Med; 2019 Aug; 20(7):485-495. PubMed ID: 31318136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.